Roche Says At-Home COVID-19 Rapid Test Gets Ok From FDA

A box of material for rapid COVID-19 antigenic tests made by Swiss drugmaker Roche is pictured at the University Hospital (CHUV) during the coronavirus disease (COVID-19) outbreak in Lausanne, Switzerland, on Nov. 13, 2020. Denis Balibouse/Reuters

Roche said on Friday that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to its COVID-19 at-home rapid test that can be used by people as young as 14.

The test, which uses an anterior nasal swab sample, is “able to produce accurate, reliable, and quick results in as few as 20 minutes” for SARS-CoV-2 and all variants of concern, including Omicron, the drugmaker said in a statement.